Latvia - Hospital Average Length of Stay for Malignant Neoplasm of Prostate
Since 2014, Latvia Hospital Average Length of Stay for Malignant Neoplasm of Prostate was down by 1.6% year on year. In 2019, the country was ranked number 8 comparing other countries in Hospital Average Length of Stay for Malignant Neoplasm of Prostate at 8.3 Days. Latvia is overtaken by Luxembourg, which was number 7 with 9.5 Days and is followed by Finland at 7.6 Days. South Korea lead the ranking with 15.9 Days in 2019, that is stable compared to 2018. New Zealand, Lithuania and Slovakia respectively ranked number 2, 3 and 4 in this ranking. New Zealand witnessed the best average annual growth at +2.2% per year, while Mexico recorded the worst performance at -8.8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 8.30 |
| 2018 | 8.40 |
| 2017 | 8.40 |
| 2016 | 7.70 |
| 2015 | 9.00 |
Download all data from 2013 to 2019
How does Latvia rank in Hospital Average Length of Stay for Malignant Neoplasm of Prostate?
| # | 32 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
15.90 | 2019 | +0.0 % | -0.9 % | View data | |
| 2 |
#2
New Zealand
|
11.60 | 2019 | -0.8 % | +2.2 % | View data | |
| 7 |
#7
Luxembourg
|
9.50 | 2019 | +0.0 % | +1.3 % | View data | |
| 8 |
#8
Latvia
|
8.30 | 2019 | -1.2 % | -1.6 % | View data | |
| 9 |
#9
Czech Republic
|
7.60 | 2019 | -3.8 % | -2.2 % | View data | |